Inhibition of CRISPR-Cas9 with Bacteriophage Proteins.
Inhibition of CRISPR-Cas9 with Bacteriophage Proteins.
复制标题
DOI:
10.1016/j.cell.2016.12.009
复制
发表时间:
2017-01-12
期刊:
影响因子:
64.5
通讯作者:
Bondy-Denomy J
中科院分区:
文献类型:
--
作者:
Rauch BJ;Silvis MR;Hultquist JF;Waters CS;McGregor MJ;Krogan NJ;Bondy-Denomy J
Bacterial CRISPR-Cas systems utilize sequence-specific RNA-guided nucleases to defend against bacteriophage infection. As a counter-measure, numerous phages are known that produce proteins to block the function of Class 1 CRISPR-Cas systems. However, currently no proteins are known to inhibit the widely used Class 2 CRISPR-Cas9 system. To find these inhibitors, we searched cas9-containing bacterial genomes for the co-existence of a CRISPR spacer and its target, a potential indicator for CRISPR inhibition. This analysis led to the discovery of four unique type II-A CRISPR-Cas9 inhibitor proteins encoded by Listeria monocytogenes prophages. More than half of L. monocytogenes strains with cas9 contain at least one prophage-encoded inhibitor, suggesting widespread CRISPR-Cas9 inactivation. Two of these inhibitors also blocked the widely used Streptococcus pyogenes Cas9 when assayed in Escherichia coli and human cells. These natural Cas9-specific “anti-CRISPRs” present tools that can be used to regulate the genome engineering activities of CRISPR-Cas9. Four CRISPR-Cas9 inhibitor proteins encoded by Listeria monocytogenes prophages prevent Cas9 binding and gene editing in bacteria and human cells, including currently the most widely used Cas9 from Streptococcus pyogenes.